ERα36 is an effective target of epigallocatechin-3-gallate in hepatocellular carcinoma

Epigallocatechin-3-gallate (EGCG) is a natural product with potential anti-cancer property whose direct target has not been identified. This study intended to investigate ERα36, a new isoform of estrogen receptor alpha (ERa), as a therapeutic target of EGCG in hepatocellular carcinoma (HCC). In this...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Int J Clin Exp Pathol
Prif Awduron: Chen, Jing, Chen, Lihong, Lu, Ting, Xie, Yuqiong, Li, Chunchun, Jia, Zhenyu, Cao, Jiang
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: e-Century Publishing Corporation 2019
Pynciau:
Original Article
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC6949832/
https://ncbi.nlm.nih.gov/pubmed/31934166
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg